Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
NCT00262353 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-07-02
Summary
Comparison of the efficacy of dialysis by conventional dialysis versus Prometheus artificial hepatic system
Conditions
- Renal Failure, Chronic
Interventions
- DEVICE
-
Dialysis with different artificial devices
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Raymond Vanholder, MD, PhD · University Hospital, Ghent
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Belgium
Study Locations
More Related Trials
-
Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane
NCT00230906 ·Status: COMPLETED ·Phase: NA
-
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
NCT06646328 ·Status: TERMINATED ·Phase: PHASE4
-
Influence Continuous Veno-venous Hemodialysis the Autoregulation
NCT01376531 ·Status: COMPLETED
-
Acute Renal Failure Trial Network (ATN) Study
NCT00076219 ·Status: COMPLETED ·Phase: PHASE3
-
Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis
NCT00752453 ·Status: COMPLETED ·Phase: NA
-
Proenkephalin A and Kidney Replacement Therapy
NCT04879706 ·Status: TERMINATED
-
Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy
NCT01269112 ·Status: COMPLETED ·Phase: PHASE4
-
Hypertension in Hemodialysis
NCT00067665 ·Status: COMPLETED ·Phase: NA
-
Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis
NCT02533609 ·Status: UNKNOWN
-
Investigating Different Anticoagulants for Renal Replacement Therapy
NCT02669589 ·Status: COMPLETED ·Phase: PHASE4
-
Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator
NCT06696235 ·Status: RECRUITING ·Phase: PHASE4
-
Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting
NCT06140563 ·Status: COMPLETED ·Phase: NA
-
The Role of P-cresol and Related Protein Fermentation Metabolites in Chronic Kidney Disease Patients
NCT00441623 ·Status: COMPLETED
-
Prevention of Acute Kidney Injury - Molecular Mechanisms of Dietary Pre-conditioning in Human
NCT02745444 ·Status: COMPLETED ·Phase: NA
-
Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis
NCT02620969 ·Status: COMPLETED
-
Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry
NCT03314363 ·Status: COMPLETED ·Phase: NA
-
Essential Nutrients in Critically Ill Patients With Severe AKI Treated With and Without CRRT
NCT02470520 ·Status: COMPLETED
-
Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
NCT00117416 ·Status: WITHDRAWN ·Phase: NA
-
Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients
NCT02499185 ·Status: TERMINATED ·Phase: PHASE4
-
Uremic Toxins of Patients With Acute Kidney Failure
NCT00148044 ·Status: COMPLETED
-
Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure
NCT00322933 ·Status: TERMINATED
-
Prevention of Akute Kidney Injury, Hearttransplant, ANP
NCT02665377 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
NCT01072682 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis
NCT00877370 ·Status: COMPLETED ·Phase: PHASE4
-
A Zero Acute Kidney Injury Strategy for Percutaneous Coronary Intervention in Patients With ChronicKidney Disease
NCT04928092 ·Status: WITHDRAWN